| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
| filingDate |
2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4b328b8a29c010840da1642c4e43a73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d54efe712c11d16e37b37398634db3 |
| publicationDate |
2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2015193573-A |
| titleOfInvention |
Imidazoline derivatives and uses thereof |
| abstract |
The present invention provides an adrenergic α1A receptor selective full agonist useful for elucidation of physiological actions via an adrenergic α1A receptor. The present invention provides an imidazoline derivative represented by the following or a pharmaceutically acceptable acid addition salt thereof. [Selection figure] None |
| priorityDate |
2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |